These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 87553)

  • 1. Wiskott-Aldrich syndrome: detection of carrier state by metabolic stress of platelets.
    Shapiro RS; Gerrard JM; Perry GS; White JG; Krivit W; Kersey JH
    Lancet; 1978 Jan; 1(8056):121-3. PubMed ID: 87553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Wiskott-Aldrich syndrome: studies on a possible defect in mitochondrial ATP resynthesis in platelets.
    Akkerman JW; van Brederode W; Gorter G; Zegers BJ; Kuis W
    Br J Haematol; 1982 Aug; 51(4):561-8. PubMed ID: 7104236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet abnormality in Wiskott-Aldrich syndrome.
    Hadden JW; Holmes-Gray B; Good RA
    N Engl J Med; 1970 Oct; 283(16):876-7. PubMed ID: 4248132
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of platelet response to stimulation in the Wiskott-Aldrich syndrome.
    Kuramoto A; Steiner M; Baldini MG
    N Engl J Med; 1970 Feb; 282(9):475-9. PubMed ID: 5411870
    [No Abstract]   [Full Text] [Related]  

  • 5. Impaired energy metabolism in platelets from patients with Wiskott-Aldrich syndrome.
    Verhoeven AJ; van Oostrum IE; van Haarlem H; Akkerman JW
    Thromb Haemost; 1989 Feb; 61(1):10-4. PubMed ID: 2749583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wiskott-Aldrich syndrome: studies of platelets, basophils and polymorphonuclear leucocytes.
    Marone G; Albini F; di Martino L; Quattrin S; Poto S; Condorelli M
    Br J Haematol; 1986 Apr; 62(4):737-45. PubMed ID: 2421757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of carrier status for the Wiskott-Aldrich syndrome by flow cytometric analysis of Wiskott-Aldrich syndrome protein expression in peripheral blood mononuclear cells.
    Yamada M; Ariga T; Kawamura N; Yamaguchi K; Ohtsu M; Nelson DL; Kondoh T; Kobayashi I; Okano M; Kobayashi K; Sakiyama Y
    J Immunol; 2000 Jul; 165(2):1119-22. PubMed ID: 10878391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ultrastructure of the blood platelets in Wiskott-Aldrich syndrome].
    Trung PH; Griscelli C; Mozziconacci P
    Pathol Biol (Paris); 1975 Jan; 23(1):57-62. PubMed ID: 1105327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic exclusion of glucose-6-phosphate dehydrogenase in platelets and T lymphocytes from a Wiskott-Aldrich syndrome carrier.
    Gealy WJ; Dwyer JM; Harley JB
    Lancet; 1980 Jan; 1(8159):63-5. PubMed ID: 6101415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation.
    Ingrungruanglert P; Amarinthnukrowh P; Rungsiwiwut R; Maneesri-le Grand S; Sosothikul D; Suphapeetiporn K; Israsena N; Shotelersuk V
    Thromb Haemost; 2015 Apr; 113(4):792-805. PubMed ID: 25518736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet actin nodules are podosome-like structures dependent on Wiskott-Aldrich syndrome protein and ARP2/3 complex.
    Poulter NS; Pollitt AY; Davies A; Malinova D; Nash GB; Hannon MJ; Pikramenou Z; Rappoport JZ; Hartwig JH; Owen DM; Thrasher AJ; Watson SP; Thomas SG
    Nat Commun; 2015 Jun; 6():7254. PubMed ID: 26028144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False-negative prenatal exclusion of Wiskott-Aldrich syndrome by measurement of fetal platelet count and size.
    Lorenz P; Bollmann R; Hinkel GK; Mächler M; Siegert G; Stamminger G; Wendisch J; Ziemer S
    Prenat Diagn; 1991 Nov; 11(11):819-25. PubMed ID: 1754554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wiskott-Aldrich syndrome: cellular impairments and their implication for carrier detection.
    Prchal JT; Carroll AJ; Prchal JF; Crist WM; Skalka HW; Gealy WJ; Harley J; Malluh A
    Blood; 1980 Dec; 56(6):1048-54. PubMed ID: 7437512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enigma of the Wiskott-Aldrich syndrome begins to unravel.
    Rosen FS
    J Clin Invest; 1996 Jun; 97(11):2407. PubMed ID: 8647931
    [No Abstract]   [Full Text] [Related]  

  • 15. WASP levels in platelets and lymphocytes of wiskott-aldrich syndrome patients correlate with cell dysfunction.
    Shcherbina A; Rosen FS; Remold-O'Donnell E
    J Immunol; 1999 Dec; 163(11):6314-20. PubMed ID: 10570326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unique presentation of Wiskott-Aldrich syndrome in relation to platelet size.
    Patel PD; Samanich JM; Mitchell WB; Manwani D
    Pediatr Blood Cancer; 2011 Jul; 56(7):1127-9. PubMed ID: 21488158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of two novel WASP gene mutations in 3 boys with Wiskott-Aldrich syndrome].
    Jiang LP; Xu YH; Yang XQ; Liu EM; Wang LJ; Lau YL; Chan KW
    Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):590-3. PubMed ID: 14744380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antimycin and 2-deoxyglucose on adenine nucleotides in human platelets. Role of metabolic adenosine triphosphate in primary aggregation, secondary aggregation and shape change of platetets.
    Holmsen H; Setkowsky CA; Day HJ
    Biochem J; 1974 Nov; 144(2):385-96. PubMed ID: 4462589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wiskott-Aldrich Syndrome: Description of a New Gene Mutation With Normal Platelet Volume.
    Yoonessi L; Randhawa I; Nussbaum E; Saharti S; Do P; Chin T; Zwerdling T
    J Pediatr Hematol Oncol; 2015 Oct; 37(7):515-8. PubMed ID: 26241726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wiskott-Aldrich Syndrome: Description of a New Gene Mutation Without Immunodeficiency.
    Howard K; Hall CP; Al-Rahawan MM
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):163. PubMed ID: 26583625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.